# NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.

> **NCT07063810** · NA · NOT_YET_RECRUITING · sponsor: **Slb Pharma** · enrollment: 120 (estimated)

## Conditions studied

- Neurological Conditions
- Brain Diseases
- Cerebral Palsy
- Parkinson Disease (PD)
- Multiple Sclerosis
- Head Trauma
- Ischemic Stroke
- Cerebral Anoxia

## Interventions

- **DEVICE:** Mixed Reality Rehabilitation

## Key facts

- **NCT ID:** NCT07063810
- **Lead sponsor:** Slb Pharma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063810, "NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07063810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*